VINZENZ GRUPPE
     
 

Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma

Li, S, Peck-Radosavljevic, M, Kienast, O, Preitfellner, J, Havlik, E, Schima, W, Traub-Weidinger, T, Graf, S, Beheshti, M, Schmid, M, Angelberger, P and Dudczak, R (2004) Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 48 (3). pp. 198-206. ISSN 1824-4785

[thumbnail of Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma] Text (Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma)
2 - 2004 QJNMMI Li.pdf
Restricted to Registered users only

Download (131kB)
Item Type: Fachpublikation (peer reviewed)
Divisions: Ordensklinikum Linz Barmherzige Schwestern > Nuklearmedizin
Depositing User: Prof. Werner Langsteger
Date Deposited: 19 Mar 2019 12:22
Last Modified: 17 Feb 2025 09:33
URI: https://eprints.vinzenzgruppe.at/id/eprint/8605
Edit Item Edit Item